Literature DB >> 9258655

Variable FHIT transcripts in non-neoplastic tissues.

I Panagopoulos1, S Thelin, F Mertens, F Mitelman, P Aman.   

Abstract

We used nested reverse transcriptase PCR to investigate the expression of the FHIT gene, a presumptive tumor suppressor gene located in chromosomal band 3p 14.2, in non-neoplastic samples. Multiple transcripts of the FHIT gene were found in peripheral blood lymphocytes, skeletal muscle, and liver of healthy individuals, as well as in a cell line derived from isynovial tissue. The data indicate that variable splicing of the FHIT transcript, leading to deletions of exons and thus anomalous or absent FHIT protein production, occurs frequently in non-neoplastic tissues. Hence, the finding of multiple nonfunctional FHIT transcripts is not tumor-specific and cannot be used as a genetic marker of neoplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258655     DOI: 10.1002/(sici)1098-2264(199708)19:4<215::aid-gcc2>3.0.co;2-#

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.

Authors:  Y Shi; M Zou; N R Farid; M C Paterson
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

2.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.

Authors:  R M Gemmill; J D West; F Boldog; N Tanaka; L J Robinson; D I Smith; F Li; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans.

Authors:  Y Pekarsky; M Campiglio; Z Siprashvili; T Druck; Y Sedkov; S Tillib; A Draganescu; P Wermuth; J H Rothman; K Huebner; A M Buchberg; A Mazo; C Brenner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

4.  Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients.

Authors:  Heba M S Ismail; Amina M Medhat; Amr M Karim; Nadia I Zakhary
Journal:  Int J Breast Cancer       Date:  2011-10-19

5.  Abnormalities of the FHIT gene in human oral carcinogenesis.

Authors:  K Tanimoto; S Hayashi; E Tsuchiya; Y Tokuchi; Y Kobayashi; K Yoshiga; T Okui; M Kobayashi; T Ichikawa
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

6.  Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  T Schlott; K Ahrens; I Ruschenburg; S Reimer; H Hartmann; M Droese
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Impaired FHIT expression characterizes serous ovarian carcinoma.

Authors:  K Ozaki; T Enomoto; K Yoshino; M Fujita; G S Buzard; K Kawano; M Yamasaki; Y Murata
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

8.  Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells.

Authors:  M Carapeti; R C Aguiar; H Sill; J M Goldman; N C Cross
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

9.  Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma.

Authors:  S Hinohara; N Satake; K Sekine; Y Kaneko
Journal:  Jpn J Cancer Res       Date:  1998-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.